Publications by authors named "Mathilde Barrau"

Claim this Profile
C
Comparing standard versus intensified pneumococcal vaccination regimens in patients with inflammatory bowel disease on biologics: a prospective, multicenter, randomized, open-label study.
Xavier Roblin, Sophie Vieujean, Stéphane Nancey, Xavier Hebuterne, Nadia Arab-Hocine, Mathilde Barrau

J Crohns Colitis· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictive Factors of Cytomegalovirus Colonic Reactivation in Patients with Active Ulcerative Colitis.
Alexandre Jentzer, Aymeric Cantais, Xavier Roblin, Mathilde Barrau, Arnauld Garcin

Viruses· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development and evaluation of two whole-blood flow cytometry protocols for monitoring patients treated with JAK inhibitors.
Louis Waeckel, Chloé Talon, Mathilde Barrau, Anne-Emmanuelle Berger, Xavier Roblin

Immunother Adv· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Avolition Characterizes the Chronic Fatigue Experienced in Quiescent Inflammatory Bowel Disease.
Tristan Gabriel-Segard, Margherita Boltri, Mathilde Barrau, Catherine Massoubre, Stéphane Paul

Biomedicines· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risankizumab Concentration but not IL-22 Levels Are Associated With Clinical and Biochemical Remission in Patients With Crohn's Disease.
Xavier Roblin, Estelle Moschetti, Mathilde Barrau, Adam S Cheifetz, Konstantinos Papamichael

Clin Gastroenterol Hepatol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adalimumab Drug Levels at Secondary Loss of Response Do Not Predict Response to Dose-intensification in Crohn's Disease: A Retrospective, International Multicenter Study.
Robert D Little, Adrian Swaine, Rebecca Reynolds, David J Gibson, Mathilde Barrau

Inflamm Bowel Dis· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Higher Serum Infliximab Concentrations Following Subcutaneous Dosing are Associated with Deep Remission in Patients with Inflammatory Bowel Disease.
Xavier Roblin, Stéphane Nancey, Konstantinos Papamichael, Gérard Duru, Mathurin Flamand, Mathilde Barrau

J Crohns Colitis· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New methods to unveil host-microbe interaction mechanisms along the microbiota-gut-brain-axis.
Habibullah Moradian, Tristan Gabriel, Mathilde Barrau, Xavier Roblin, Stéphane Paul

Gut Microbes· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proton pump inhibitors and risk of severe COVID-19 in older people.
Baptiste Gramont, Sophie Fayolle, Diva Beltramin, Nisrine Bidat, Julie Boudet, Mathilde Barrau

Age Ageing· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
What Should We Know about Drug Levels and Therapeutic Drug Monitoring during Pregnancy and Breastfeeding in Inflammatory Bowel Disease under Biologic Therapy?
Mathilde Barrau, Xavier Roblin, Leslie Andromaque, Aurore Rozieres, Mathias Faure

J Clin Med· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of Antibodies to Ustekinumab Is Associated with Loss of Response in Patients with Inflammatory Bowel Disease.
Xavier Roblin, Gérard Duru, Konstantinos Papamichael, Adam S Cheifetz, Sandy Kwiatek, Mathilde Barrau

J Clin Med· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Systematic Review on the Interest of Drug-tolerant Assay in the Monitoring of Inflammatory Bowel Disease.
Mathilde Barrau, Manon Duprat, Pauline Veyrard, Quentin Tournier, Nicolas Williet

J Crohns Colitis· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subcutaneous injection of infliximab CT-P13 results in stable drug levels within 14-day treatment cycle in Crohn's disease.
Xavier Roblin, Pauline Veyrard, Laetitia Bastide, Anne E Berger, Mathilde Barrau

Aliment Pharmacol Ther· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early venous thromboembolism is a strong prognostic factor in patients with advanced pancreatic ductal adenocarcinoma.
Mathilde Barrau, Khawla Maoui, Bertrand Le Roy, Xavier Roblin, Patrick Mismetti

J Cancer Res Clin Oncol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis